Loading clinical trials...
Loading clinical trials...
Randomized, Double-Blind, Multi-Center, Phase 3 Trial to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Hydrochlorothiazide Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients Not Controlled by Telmisartan/Amlodipine Combination
Conditions
Interventions
Telmisartan/Amlodipine+Hydrochlorothiazide
Telmisartan/Amlodipine
+1 more
Locations
1
South Korea
Seoul National University Hospital
Seoul, South Korea
Start Date
May 1, 2015
Primary Completion Date
August 1, 2016
Completion Date
August 1, 2016
Last Updated
November 25, 2016
NCT06823947
NCT06604897
NCT07448506
NCT07433790
NCT07421388
NCT07421414
Lead Sponsor
IlDong Pharmaceutical Co Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions